
Halle C. F. Moore, MD
Advertisement
Articles by Halle C. F. Moore, MD


This video reviews a meta-analysis that looked at five studies testing the use of a gonadotropin-releasing hormone (GnRH) analog to protect ovarian function and preserve fertility in premenopausal women undergoing chemotherapy for early-stage breast cancer.

This review will focus largely on the effects of systemic cytotoxic treatment on cognitive function, reflecting what has been most extensively studied in the literature.
Advertisement
Latest Updated Articles
An Overview of Chemotherapy-Related Cognitive Dysfunction, or ‘Chemobrain’Published: September 15th 2014 | Updated:
Meta-Analysis: GnRH Analog Preserves Ovarian Function in Early Breast CancerPublished: December 14th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
4
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
5

